Abstract 2057P
Background
Aging-related deficits that eventually manifest as frailty are emerging as an important determinant for quality of life and emotional health in older patients with cancer. Prevalence of frailty in long-term prostate cancer survivors and its impact on quality of life have not been investigated so far. The objective of the current study was (I) to assess the prevalence of frailty and (II) to elucidate the relationship between frailty, quality of life and emotional health in long-term prostate cancer survivors after radical prostatectomy.
Methods
2979 prostate cancer survivors from the multicenter German Familial Prostate Cancer Database were included. Patients completed the following standardized patient-reported outcome measures of interest: frailty (Groningen Frailty Indicator, GFI), quality of life (EORTC QL2), and emotional health (anxiety/depression symptoms, PHQ-4). Chi-square tests and Wilcoxon-Mann-Whitney tests were used to detect differences of selected variables between frail and non-frail patients. Associations were assessed using multiple linear regression analysis.
Results
The patients’ mean age was 79.4 years (SD = 6.4) and mean time since radical prostatectomy was 17.4 years (SD = 3.8). 33.1% (985/2979) of patients were classified as frail (GFI ≥4). Regarding mental health and quality of life, frail patients reported more often symptoms of depression (24.0% vs. 4.0%; p<0.001) and anxiety (20.6% vs. 2.0%; p<0.001) as well as lower quality of life (M = 53.4 (SD = 19.2) vs. M = 72.7 (SD = 16.0); p<0.001) compared to non-frail patients. Frailty was significantly associated with depression (OR 1.68; CI 1.49-1.89), anxiety (OR 1.75; CI 1.55-1.97), lower quality of life (OR 0.72; CI 0.67-0.77), higher age (OR 1.04; CI 1.03-1.07), and a missing partnership (OR 1.83; CI 1.37-2.45).
Conclusions
Every third long-term prostate cancer survivor after radical prostatectomy was frail. The associations with lower quality of life and poorer mental health indicates the need for an integrated care approach including further geriatric assessment and possible interventions to improve health outcomes of these patients.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2116P - Preoperative body mass index, waist circumference, and mortality after major cancer surgery: A nationwide cohort study in South Korea
Presenter: Jiwon Yoon
Session: Poster session 06
2117P - Dietary patterns and clinical outcomes in patients with lung cancer: What needs to change
Presenter: Imanuely Borchardt
Session: Poster session 06
2118P - Refeeding syndrome: A prospective analysis in adults admitted to an oncology hospital
Presenter: Filipe Gonçalves
Session: Poster session 06
2119P - The prognostic impact of nutritional assessment and scores in advanced gastric cancer
Presenter: Sara Torresan
Session: Poster session 06
2120P - Nutritional deficiency post gastric cancer surgery
Presenter: Abay Makishev
Session: Poster session 06
2121P - Association between nutritional status and adverse events in gastrointestinal cancer patients undergoing outpatient chemotherapy in Japan
Presenter: Naoko Sato
Session: Poster session 06
2122P - Clinical significance of oncology patients’ nutritional status assessment
Presenter: Efthymios Kostaridis
Session: Poster session 06
2123P - Value of immuno-nutritional scores in the prognosis of hospitalised patients with lung cancer
Presenter: Jesús López
Session: Poster session 06
2124P - The impact of NUTRItional status at first medical oncology visit ON Clinical Outcomes: The NUTRIONCO study
Presenter: Maurizio Muscaritoli
Session: Poster session 06
2125P - Potential ROle of hypoVItaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): A prospective observational study
Presenter: Alessio Cortellini
Session: Poster session 06